课题基金 / 基金详情

项目摘要

项目成果

Meenhard F Herlyn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary – PDX Core B The PDX Core provides major resources to the program investigators, including melanoma PDX, melanoma cell lines and 3D models such as organoids, spheres, and spheroids, to explore new therapies. Our melanoma PDX pre-clinical platform encompasses >500 different tumors representing all clinical, biologic, and genetic groups of the disease. The primary focus of the PDX Core is to establish, bank and distribuite new PDX and PDX-derived models. The PDX Core also coordinates the characterization the pre-clinical melanoma models at at the biological (e.g. growth and metastasis) and molecular (e.g. DNA- and RNA-sequencing, and protein expression) levels. The core maintains a master cell bank, conducts quality control of specimens and derived models and monitors for mouse pathogens. The core is also the central facilitator for exchanging PDX within the PDXNet and coordinates collaborations with other investigators within the program, the overall PDXNet and outside scientists. The core coordinates data storage, data sharing and distribution to other investigators within the program. The PDX Core is available to train investigators of the program in all biological assays and models. Overall, this core will provide efficient and high-quality service to all investigators within this PDTC. The PDX Core is also available to assist investigators withinPDXNet and collaborators as requested. 1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gamma delta T cell based melanoma therapies
  • 批准号:
    10365762
  • 项目类别:
  • 资助金额:
    $66.67万
  • 财政年份:
    2021
  • 负责人:
    Meenhard F Herlyn
  • 依托单位:
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
  • 批准号:
    10381269
  • 项目类别:
  • 资助金额:
    $4.62万
  • 财政年份:
    2021
  • 负责人:
    Meenhard F Herlyn
  • 依托单位:
Administrative Core
  • 批准号:
    10268741
  • 项目类别:
  • 资助金额:
    $21.79万
  • 财政年份:
    2021
  • 负责人:
    Meenhard F Herlyn
  • 依托单位:
Neoadjuvant immunotherapy approaches to early stage melanoma
  • 批准号:
    10480856
  • 项目类别:
  • 资助金额:
    $44.02万
  • 财政年份:
    2021
  • 负责人:
    Meenhard F Herlyn
  • 依托单位:
海外基金